The case presented here demonstrates a remarkable response to chemoimmunotherapy in a patient with metastatic ESCC, dMMR due to isolated PMS2 loss, and a low but positive PD-L1 CPS of 1. The gene discussed is PMS2; the disease is esophageal squamous cell carcinoma.